HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AP24534

Protein Kinase Inhibitor; structure in first source
Also Known As:
3-(2-(imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide; AP 24534; AP-24534
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Rivera, Victor M: 4 articles (03/2012 - 11/2009)
2. Gozgit, Joseph M: 3 articles (05/2013 - 06/2011)
3. Clackson, Tim: 3 articles (03/2012 - 11/2009)
4. Shakespeare, William C: 3 articles (03/2012 - 11/2009)
5. Wang, Frank: 3 articles (03/2012 - 11/2009)
6. Wardwell, Scott: 3 articles (03/2012 - 11/2009)
7. Druker, Brian J: 3 articles (11/2011 - 11/2009)
8. Zhu, Xiaotian: 2 articles (04/2013 - 11/2009)
9. Mohemmad, Qurish K: 2 articles (03/2012 - 06/2011)
10. Wong, Matthew J: 2 articles (03/2012 - 06/2011)

Related Diseases

1. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
2. Hematologic Neoplasms (Hematological Malignancy)
3. Neoplasms (Cancer)
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
5. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

Related Drugs and Biologics

1. Protein-Tyrosine Kinases (Tyrosine Kinase)
2. Adenosine Triphosphate (ATP)
3. 4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)
4. dasatinib (BMS 354825)